Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A review of adverse events reported to the FDA raises concern about the relative safety of rosuvastatin (Crestor) at its commonly used doses, researchers say. Some health professionals downplayed the study, however, saying the results still highlight the safety of statins for their indicated uses.

Research News: AE analysis raises safety questions about Crestor